Cytokine expression during syphilis infection in HIV-1-infected individuals

Sexually Transmitted Diseases

Volumn 36, Issue 5, 2009, Pages 300-304

  Knudsen, Andreas ^a   Benfield, Thomas ^a   Kofoed, Kristian ^a,b  

^a Mental Health Center Glostrup   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BENZATHINE PENICILLIN; DOXYCYCLINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA; CYTOKINE;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LATENT PERIOD; MALE; MIXED INFECTION; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SYPHILIS; TREPONEMA PALLIDUM; BIOSYNTHESIS; BLOOD; CD4 LYMPHOCYTE COUNT; FEMALE; IMMUNOLOGY; MIDDLE AGED; UPREGULATION;

ADULT; CD4 LYMPHOCYTE COUNT; CYTOKINES; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RNA, VIRAL; SYPHILIS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 67649991475     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e318193ca26     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention. Trends in primary and secondary syphilis and HIV infections in men who have sex with men - San Francisco and Los Angeles, California, 1998-2002. MMWR Morb Mortal Wk1y Rep 2004; 53:575-578.
2. Kofoed K, Gerstoft J, Mathiesen LR, et al. Syphilis and human immunodeficiency virus (HIV)-1 coinfection: Influence on CD4 T-cell count, HIV-1 viral load, and treatment response. Sex Transm Dis 2006; 33:143-148.
3. Buchacz K, Patel P, Taylor M, et al. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS 2004; 18:2075-2079.
4. Palacios R, Jimenez-Onate F, Aguilar M, et al. Impact of syphilis infection on HIV viral load and CD4 cell counts in HIV-infected patients. J Acquir Immun Defic Syndr 2007; 44:356-359.
5. Baker-Zander SA, Lukehart SA. Macrophage-mediated killing of opsonized Treponema pallidum, J Infect Dis 1992; 165:69-74.
6. Radolf JD, Arndt LL, Akins DR, et al. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J Immunol 1995; 154:2866-2877.
7. Van Voorhis WC, Barrett LK, Koelle DM, et al. Primary and secondary syphilis lesions contain mRNA for Thl cytokines. J Infect Dis 1996; 173:491-495.
8. Leader BT, Godornes C, Van Voorhis WC, et al. CD4+ lymphocytes and gamma interferon predominate in local immune responses in early experimental syphilis. Infect Immun 2007; 75: 3021-3026.
9. Podwinska J, Lusiak M, Zaba R, et al. The pattern and level of cytokines secreted by Thl and Th2 lymphocytes of syphilitic patients correlate to the progression of the disease. FEMS Immunol Med Microbiol 2000; 28:1-14.
10. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Morb Mortal Wkly Rep 2002; 51:1-78.
11. Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126:946-954.
12. McCune JM. The dynamics of CD4+ T-cell depletion in HIV disease. Nature 2001; 410:974-979.
13. Stylianou E, Aukrust P, Kvale D, et al. IL-10 in HIV infection: Increasing serum IL-10 levels with disease progression-downregulatory effect of potent anti-retroviral therapy. Clin Exp Immunol 1999; 116:115-120.
14. Aukrust P, Müller F, Lien E, et al. Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure. J Infect Dis 1999; 179:74-82.
15. Poli G, Kinter A, Justement JS, et al. Tumor necrosis factor α functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sci U S A 1990; 87:782-785.
16. Weissman D, Poli G, Fauci AS. IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 9:442-449.
17. Finnegan A, Roebuck KA, Nakai BE, et al. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage. J Immunol 1996; 156:841-851.
18. Rabbi MF, Finnegan A, Al-Harthi L, et al. Interleukin-10 enhances tumor necrosis factor-alpha activation of HIV-1 transcription in latently infected T cells. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:321-331.
19. Couper KN, Blount DG, Riley EM. IL-10: The master regulator of immunity to infection. J Immunol 2008; 180:5771-5777.
20. Redpath S, Ghazal P, Gascoigne NR. Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol 2001; 9:86-92.
21. Mege JL, Meghari S, Honstettre A, et al. The two faces of interleukin 10 in human infectious diseases. Lancet Infect Dis 2006; 6:557-569.
22. Brooks DG, Trifilo MJ, Edelmann KH, et al. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 2006; 12:1301-1309.
23. Lazarus JJ, Meadows MJ, Lintner RE, et al. IL-10 deficiency promotes increased Borrelia burgdorferi clearance predominantly through enhanced innate immune responses. J Immunol 2006; 177:7076-7085.
24. Schuitemaker H, Kootstra NA, Koppelman MH, et al. Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages. J Clin Invest 1992; 89:1154-1160.
25. Kofoed K, Schneider UV, Scheel T, et al. Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology. Clin Chem 2006; 52:1284-1293.